• CaPP3: progress towards a launch in 2013

    CaPP3: progress towards a launch in 2013

    CaPP3: progress towards a launch in 2013

  • CAPP2 Paper Released

    CAPP2 Paper Released

    On October 28th 2011 the CAPP2 paper was published in the Lancet, click to find out more.

  • CaPP3 is go!

    CaPP3 is go!

    Now that we have the result of the CAPP2 study which shows that regular aspirin significantly reduces cancer risk in Lynch syndrome, we now need to try and work out the best dose.

Previous Next

Latest News

Downloads & Links

  • CAPP2 protocol

    posted on Tuesday, 9th October 2012

  • CAPP2 Paper October 2011

    posted on Thursday, 27th October 2011

    Research has finally provided proof that taking a regular dose of aspirin reduces the long-term risk of cancer in people with a family history of the disease by around 60 per cent.

397

Participants registered interest

5

Countries

78

Healthcare professionals registered interest